Main Article Content


The red cells transfusion is a mainstay in the treatment of anemic patients. These blood transfusions are not without risks.The risk-benefit profile for red cell transfusions to treat anaemia is uncertain, but they may contribute to adverse patient outcomes in some situations. The ability of a patient to tolerate anaemia depends on their clinical condition and the presence of any significant co-morbidity; maintenance of circulating volume is of paramount importance. There is no universal transfusion trigger. Advances in the development and validation of physiological, accessible, practical and reliable markers to guide therapy are expected. To improve patients’ outcomes, further study is required to more fully explore the risk of anemia, optimal hemoglobin level, and the risk and efficacy of RBC transfusion. Future clinical investigations with high priority should determine the efficacy of transfusion in those classified as uncertain scenarios. In the absence of data, it is prudent that transfusion is administered with caution in these clinical scenarios.


Cortés, A. (2014). Anemia and transfusion of red blood cells. Colombia Medica, 44(4), 236–242.

AABB. The 2007 national blood collection and utilization survey report. programs/biovigilance/nbcus/Documents/07nbcusrpt.pdf. Accessed 15 April 2011.

Perioperative Red Cell Transfusion. NIH Consens Dev Conf Consens Statement. 1988; 7(4): 1-19.

Weiskopf RB. Do we know when to transfuse red cells to treat acute anemia?. Transfusion 1998; 38: 517-21.

Marik PE, Corwin HL. Eficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crít Care Med. 2008; 36: 2667–74.

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340: 409-17.

Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crít Care Med. 2001; 29: 227-34.

Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007; 356: 1609-19.

Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, et al. LBA-6 Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS): The principle results. Paper presented at the 51st Annua l Meeting of the American Society of Hematology, December 5-9, 2009.

Napolitano LM, Corwin HL. Efficacy of red blood cell transfusion in the critically ill. Crít Care Clin. 2004; 20: 255-68.

Madjdpour C, Spahn DR. Allogeneic red blood cell transfusion: Physiology of oxygen transport. Best Pract Res Clin Anaesthesiol. 2007; 21: 163-71.

Vincent JL, Sakr Y, De Backer D, Van der Linden P. Efficacy of allogeneic red blood cell transfusions. Best Pract Res Clin Anaesthesiol. 2007; 21: 209-19.

Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crít Care. 2001; 5: 362-7.

Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crít Care Med. 2004; 32: 39-52.

Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A. et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002; 288: 1499-1507.

Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003; 54: 908-14.

Palmieri TL, Caruso DM, Foster KN, Cairns BA, Peck MD, Gamelli RL. et al. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crít Care Med. 2006; 34: 1602-7.

Stone TJ, Riesenman PJ, Charles AG. Red blood cell transfusion within the first 24 hours of admission is associated with increased mortality in the pediatric trauma population: A retrospective cohort study. J Trauma Manag Outcomes. 2008; 2: 9-13.

Marik PE, Corwin HL. Eficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crít Care Med. 2008; 36: 2667–74.

Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009; 113: 3406-17.

Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P. et al. Critical oxygen delivery in conscious humans is less than 7.3 ml O2. kg-1. min-1. Anesthesiology. 2000; 92:407-13.

Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ. et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993; 270: 1724-30.

Klein H, Spahn D, Carson J. Red blood cell transfusion in clinical practice. Lancet. 2007; 370: 415-26.

Madjdpour C, Spahn D. Allogeneic red blood cell transfusions: Efficacy, risks, alternatives and indications. Br J Anesthesiol. 2005; 95: 33-42.

Madjdpour C, Spahn D, Weiskopf R. Anemia and perioperative red blood cell transfusion: A matter of tolerance. Crít Care Med. 2006; 34: S102-S8.

Gerber D. Transfusion of packed red blood cells in patients with ischemic heart disease. Crít Care Med. 2008; 36: 1068-74.

Nohara R. Diagnosis with O2 kinetics. Old but new. Circulation J. 2009; 73: 1795-6.

Van Woerkens EC, Trouwborst A, van Lanschot JJ: Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesth Analg. 1992; 75: 818-21.

Weiskopf RB, Feiner J, Hopf HW, Viele MK, Watson JJ, Kramer JH. et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology. 2002; 96: 871–7.

Weiskopf RB, Feiner J, Hopf H, Lieberman J, Finlay HE, Quah C. et al. Fresh blood and aged stored blood are equally eficacious in immediately reversing anemia induced brain oxygenation deficits in humans. Anesthesiology. 2006; 104: 911–20.

Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998; 279: 217–21.

Spahn DR, Smith LR, Veronee CD, McRae RL, Hu WC, Menius AJ, et al. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. JThorac Cardiovasc Surg. 1993; 105: 694–704.

Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol. 1993; 265: H340–9.

Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg. 2007; 83: s27-86.

Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crít Care Med. 2009; 37(12): 3124-57.

Wang J, Klein H. Red blood cell transfusion in the treatment and management of anaemia: The search for the elusive transfusion trigger. Vox Sang. 2010; 98: 2-11.

Vamvakas EC: Evidence-based practice of transfusion medicine: Is it possible and what do the words mean? Transfus Med Rev. 2004; 18: 267-8.

Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee. 2000; 7:151-5.

Cavaliere F, Martinelli L, Guarnieri S, Varano C, Rossi M, Schiavello R. Arterial-venous PCO2 gradient in early postoperative hours following myocardial revascularization. J Cardiovasc Surg. 1996; 37: 499-503.

Carson JI, Chen AY. In search of the transfusion trigger. Clin Orthop. 1998; 357: 30-5.

Lundsgard-Hansen P. Safe hemoglobin or hematocrit levels in surgical patients. Worl J Surg. 1996; 20: 1182-8.

Deans K, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, et al. Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols. Crit Care Med. 2007; 35: 1509-16.

Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006; 90: 105-12.

Murphy GJ, Rizvi S, Battaglia F, Culliford L, Rogres C, Cohen A, et al. A pilot randomised controlled trial of the effect of transfusion threshold reduction on transfusion rates and morbidity after cardiac surgery. Society for Cardiothoracic Surgery in Great Britain and Ireland. Annual meeting 2007; 94. Programme24Feb2007.pdf.

Slight RD, O´Donohoe P, Fung AKY, Alonzi C, McClelland DBL, Mankad PS. Rationalizing blood transfusion in cardiac surgery: the impact of a red cell volume-based guideline on blood usage and clinical outcome. Vox Sang. 2008; 95: 205-10.

Haijar LA, Vincent JL, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al. Transfusion requirements after cardiac surgery. The TRACS randomized controlled trial. JAMA. 2010; 304: 1559-67.

Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a a subgroup analysis. Crit Care Med. 2010; 38: 649-56.

Rouette J, Trottier H, Ducruet T, Beaunoyer M, Lacroix J, Tucci M. et al. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients. A randomized clinical trial. Ann Surg. 2010; 251: 421-7.

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365: 2453-62.

Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009; 49: 227-34.

Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012; 157(1):49-58.

Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the national institutes of health consensus development program on physician practice. JAMA. 1987; 258: 2708–13.

Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989; 321: 1306–11.

Hill MN, Levine DM, Whelton PK. Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health. 1988; 78: 1190–4.

Eisenstaedt RS. Modifying physicians’ transfusion practice. Transfus Med Rev. 1997; 11: 27–37.

Salem-Schatz S, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. JAMA. 1990; 264: 476–83.

Brown RL, Brown RL, Edwards JA, Nutz JF. Variation in a medical faculty’s decisions to transfuse. Implications for modifying blood product utilization. Med Care. 1992; 30(12):1083-96.


Download data is not yet available.
1 2 3 > >> 
Received 2014-01-22
Accepted 2014-01-22
Published 2014-01-24

Similar Articles

You may also start an advanced similarity search for this article.